logo
Plus   Neg
Share
Email

Belén Garijo Appointed As Deputy CEO Of Merck KGaA

The Board of Partners of E. Merck KG appointed Belén Garijo as Vice Chairman of the Executive Board and Deputy CEO of Merck KGaA effective today. She will maintain her current Executive Board responsibilities.

Udit Batra has decided to pursue other opportunities outside Merck. Effective today, the contract of Batra as General Partner of E. Merck KG and Executive Board Member of Merck KGaA has been resolved.

On an interim basis, Christos Ross will take over the Life Science business lead. Ross joined Merck in 2008 and currently serves as Executive Vice President Integrated Supply Chain Operations within the Life Science business sector.

Marcus Kuhnert, Member of the Executive Board, Chief Financial Officer and in charge of Merck Business Services and Procurement, will in addition take over the Executive Board responsibility for Information Technology.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT